Furthermore, in clear cell renal cell carcinoma (ccRCC), MFN2 can inhibit the progression of ccRCC by blocking cellular lipid metabolism and reducing lipid droplet accumulation (Cai, et al. 2024). The gene discussed is MFN2; the disease is clear cell renal carcinoma.